Loading...

NEUROTRANSMITTER DISORDERS GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited 
The Neurotransmitter Disorders Gene Panel by NGS, EDTA Blood at Metropolis Healthcare is an advanced genetic test designed to identify mutations linked to disorders affecting neurotransmitter synthesis, transport, and metabolism. These conditions can cause developmental delays, movement disorders, seizures, and autonomic dysfunction. Metropolis Healthcare uses high-depth Next-Generation Sequencing to deliver precise and clinically relevant genetic insights. This test is ideal for individuals with unexplained neurological symptoms or suspected inherited neurotransmitter disorders. Early genetic diagnosis supports targeted treatment and improved long-term outcomes.
 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:N0069

Frequently Asked Questions (FAQ's):

What does the Neurotransmitter Disorders Gene Panel at Metropolis Healthcare include?
It analyzes multiple genes involved in neurotransmitter pathways to identify mutations affecting brain signaling and metabolic function.

How does Metropolis Healthcare perform this NGS-based gene test?
Metropolis Healthcare uses high-coverage Next-Generation Sequencing followed by expert variant interpretation for accurate genetic assessment.

Who should consider taking this gene panel at Metropolis Healthcare?
Individuals with developmental delays, seizures, movement abnormalities, or suspected inherited neurotransmitter disorders should take this test.

Is fasting required for this genetic test at Metropolis Healthcare?
No fasting is required; only an EDTA blood sample is needed.

How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to detailed sequencing and comprehensive genetic analysis.

Can this test diagnose neurotransmitter-related disorders at Metropolis Healthcare?
Yes, it helps identify disease-causing mutations that support diagnosis and guide clinical management.

How accurate is the NGS technology used by Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through deep sequencing, stringent quality controls, and expert analysis.

Can the results guide treatment at Metropolis Healthcare?
Yes, identifying specific genetic mutations helps clinicians design targeted therapies and recommend genetic counseling.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab